2014
DOI: 10.1371/journal.pone.0096466
|View full text |Cite
|
Sign up to set email alerts
|

Glucocorticoid Receptor Knockdown Decreases the Antioxidant Protection of B16 Melanoma Cells: An Endocrine System-Related Mechanism that Compromises Metastatic Cell Resistance to Vascular Endothelium-Induced Tumor Cytotoxicity

Abstract: We previously reported an interorgan system in which stress-related hormones (corticosterone and noradrenaline), interleukin-6, and glutathione (GSH) coordinately regulate metastatic growth of highly aggressive B16-F10 melanoma cells. Corticosterone, at levels measured in tumor-bearing mice, also induces apoptotic cell death in metastatic cells with low GSH content. In the present study we explored the potential role of glucocorticoids in the regulation of metastatic cell death/survival during the early stages… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
26
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 26 publications
(26 citation statements)
references
References 67 publications
0
26
0
Order By: Relevance
“…Thus, suggesting an interorgan system where stress-related hormones, IL-6 and GSH coordinately regulate metastatic melanoma growth. Furthermore, GR knockdown decreased the expression and activity of γ-GCL in metastatic cells in an in vivo experiment, independently of the tumor location (liver, lung, or subcutaneous) (Obrador et al, 2014). The decrease in γ-GCL activity associated with lower intracellular GSH levels.…”
Section: Systemic Mechanismsmentioning
confidence: 84%
See 1 more Smart Citation
“…Thus, suggesting an interorgan system where stress-related hormones, IL-6 and GSH coordinately regulate metastatic melanoma growth. Furthermore, GR knockdown decreased the expression and activity of γ-GCL in metastatic cells in an in vivo experiment, independently of the tumor location (liver, lung, or subcutaneous) (Obrador et al, 2014). The decrease in γ-GCL activity associated with lower intracellular GSH levels.…”
Section: Systemic Mechanismsmentioning
confidence: 84%
“…The decrease in γ-GCL activity associated with lower intracellular GSH levels. Nrf2-and p53-dependent down-regulation of γ-GCL associated with a decrease in the activities of SOD1 and SOD2, CAT, GPX and GSR, but not of the O 2˙− generating NADPH oxidase (Obrador et al, 2014). The decrease in antioxidant protection caused a drastic decrease in the survival of metastatic cells during their interaction with endothelial cells, both in vitro and in vivo.…”
Section: Systemic Mechanismsmentioning
confidence: 93%
“…Our group has pointed out the importance of stress-related signals in metastatic melanoma growth ( 51 , 67 ). Glucocorticoids in particular are used at high doses in cancer therapy, in conjunction with other treatments, because they have proapoptotic properties in different cancer cells ( 60 ).…”
Section: Discussionmentioning
confidence: 99%
“…Glucocorticoids in particular are used at high doses in cancer therapy, in conjunction with other treatments, because they have proapoptotic properties in different cancer cells ( 60 ). Nevertheless, at the pathophysiological levels measured in plasma of tumor-bearing models, glucocorticoids show tumor-promoting activities ( 51 , 70 ). For instance, results in animal models of human breast cancer suggest that glucocorticoids inhibit tumor cell apoptosis ( 70 ).…”
Section: Discussionmentioning
confidence: 99%
“…It is impossible to supplement exogenous GSH or its precursor to affect GSH content in cells. The regulation of γ‐GCS is instrumental in the antioxidant role of GSH (Obrador et al, 2014). NQO1, which is downstream of Nrf2, triggers an antioxidant reaction and plays the role of Nrf2 (Jiang et al., 2017).…”
Section: Discussionmentioning
confidence: 99%